Main Article Content
Abstract
Introduction: Chronic kidney disease is a progressive condition that deteriorates quality of life. Patients not only face physical challenges, but also emotional and social ones, which can generate high levels of depression, anxiety, and stress.
Objective: TTo analyze the presence and intensity of depression, anxiety, and stress in people on renal replacement therapy from the city of Chihuahua.
Materials and Method: We conducted a descriptive and cross-sectional study in a medical unit specialized in kidney disease in Chihuahua (Mexico). All patients on renal replacement therapy participated (n=60). A sociodemographic form was applied for data collection, allowing the identification and characterization of participants. The DASS-21 Scale was used to assess the presence and intensity of affective states associated with depression, anxiety, and stress.
Results: Significant differences were observed according to the therapy. In peritoneal dialysis, 40% exhibited severe depression; 50%, moderate anxiety; and 45%, severe stress, while in hemodialysis the "Normal" category predominated in depression (55%) and anxiety (50%), with only 20% reporting severe stress. Additionally, a total of 83.3% reported constant thoughts about their illness and 31.7% hopelessness, evidencing a greater psychological impact in peritoneal dialysis.
Conclusions: Psychological impact in patients on renal replacement therapy, particularly on peritoneal dialysis, is highlighted. It is recommended to implement psychosocial interventions and develop comprehensive health policies that address their physical and emotional well-being holistically
Keywords
Article Details
Copyright (c) 2025 Lorena Realivazquez Pérez, Ximena Rodríguez-Reyes, Erika Yanet Portillo-Siqueiros, Alicia Meléndez-Balderrama, Gabriel Federico Santiesteban-Rodríguez, Laura Cecilia Zapata-Flores

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Author copyright notice
© Authors grant the publisher the non-exclusive licence to publish the work and consent to its use and distribution under the Creative Commons Attribution - NonCommercial 4.0 International (CC BY-NC 4.0) licence. Read the licensing information and the legal text here. This must be expressly stated wherever necessary.
References
- Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull World Health Organ. 2018;96(6):414-22. DOI: https://doi.org/10.2471/BLT.17.206441
- Santos PR, Marchiori GN, Almeida SS, Oliveira EC. Prevalence of anxiety and depression in patients undergoing hemodialysis. BMC Nephrol. 2019;20(1):1-9.
- Shafi AM, Iqbal A, Khalil RA. Depression and quality of life among hemodialysis patients: A systematic review. J Ren Care. 2022;48(3):165-75.
- Purnell TS, Auguste P, Crews DC, Lamprea-Montealegre JA, Olufade T, Greer R, et al. Comparison of quality-of-life outcomes in a US chronic kidney disease population based on treatment modality. Am J Kidney Dis. 2021;77(2):219-28.
- Gómez A, Rodríguez M, Pérez R. Impacto psicosocial de la diálisis en pacientes mexicanos: Un enfoque de salud pública. Rev Mex Nefrol. 2020;41(2):87-95. DOI: https://doi.org/10.4321/S0211-57352021000200005
- Cukor D, Ver Halen N, Fruchter Y, Hill P. Anxiety and depression in patients with end-stage renal disease. Adv Chronic Kidney Dis. 2019;26(1):12-20.
- Martínez J, Rivera L, Delgado N. Prevalencia de síntomas depresivos en pacientes en hemodiálisis en Chihuahua, México. Bol Salud Chihuahua. 2021;8(4):123-9.
- Rodríguez-Ramírez C, Grau-Valdés Y, Grau-Ábalo JA. Síntomas asociados al sufrimiento en pacientes con enfermedad renal crónica en hemodiálisis. Enferm Nefrol. 2021;24(3):295-302. DOI: https://doi.org/10.37551/S2254-28842021026
- Gerogianni G, Babatsikou F. Psychological aspects in chronic renal failure. Health Sci J. 2014;8(2):205-14.
- Htay H, Alrifai A, Turgutalp K, Ahmad G. Psychological distress and its association with socio-demographic and clinical variables in chronic kidney disease patients undergoing hemodialysis. PLoS One. 2018;13(7):e0200234.
- Instituto Nacional de Salud Pública. Datos nacionales de enfermedad renal en México. Cuernavaca (México): INSP; 2022.
- Lovibond PF, Lovibond SH. The structure of negative emotional states: Comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995;33(3):335-43. DOI: https://doi.org/10.1016/0005-7967(94)00075-U
- Secretaría de Salud. Reglamento de la Ley General de Salud en Materia de Investigación [Internet]. México: Secretaría de Salud; 1987 [consultado 2024 Dic 5]. Disponible en: http://www.dof.gob.mx/nota_detalle.phpcodigo=5339162&fecha=02/04/2014.
- Ng HJ, Tan WJ, Mooppil N, Newman SP, Griva K. Prevalence and patterns of anxiety in hemodialysis patients: A multi-national study. Nephrol Dial Transplant. 2020;35(9):1603-11.
References
Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull World Health Organ. 2018;96(6):414-22. DOI: https://doi.org/10.2471/BLT.17.206441
Santos PR, Marchiori GN, Almeida SS, Oliveira EC. Prevalence of anxiety and depression in patients undergoing hemodialysis. BMC Nephrol. 2019;20(1):1-9.
Shafi AM, Iqbal A, Khalil RA. Depression and quality of life among hemodialysis patients: A systematic review. J Ren Care. 2022;48(3):165-75.
Purnell TS, Auguste P, Crews DC, Lamprea-Montealegre JA, Olufade T, Greer R, et al. Comparison of quality-of-life outcomes in a US chronic kidney disease population based on treatment modality. Am J Kidney Dis. 2021;77(2):219-28.
Gómez A, Rodríguez M, Pérez R. Impacto psicosocial de la diálisis en pacientes mexicanos: Un enfoque de salud pública. Rev Mex Nefrol. 2020;41(2):87-95. DOI: https://doi.org/10.4321/S0211-57352021000200005
Cukor D, Ver Halen N, Fruchter Y, Hill P. Anxiety and depression in patients with end-stage renal disease. Adv Chronic Kidney Dis. 2019;26(1):12-20.
Martínez J, Rivera L, Delgado N. Prevalencia de síntomas depresivos en pacientes en hemodiálisis en Chihuahua, México. Bol Salud Chihuahua. 2021;8(4):123-9.
Rodríguez-Ramírez C, Grau-Valdés Y, Grau-Ábalo JA. Síntomas asociados al sufrimiento en pacientes con enfermedad renal crónica en hemodiálisis. Enferm Nefrol. 2021;24(3):295-302. DOI: https://doi.org/10.37551/S2254-28842021026
Gerogianni G, Babatsikou F. Psychological aspects in chronic renal failure. Health Sci J. 2014;8(2):205-14.
Htay H, Alrifai A, Turgutalp K, Ahmad G. Psychological distress and its association with socio-demographic and clinical variables in chronic kidney disease patients undergoing hemodialysis. PLoS One. 2018;13(7):e0200234.
Instituto Nacional de Salud Pública. Datos nacionales de enfermedad renal en México. Cuernavaca (México): INSP; 2022.
Lovibond PF, Lovibond SH. The structure of negative emotional states: Comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995;33(3):335-43. DOI: https://doi.org/10.1016/0005-7967(94)00075-U
Secretaría de Salud. Reglamento de la Ley General de Salud en Materia de Investigación [Internet]. México: Secretaría de Salud; 1987 [consultado 2024 Dic 5]. Disponible en: http://www.dof.gob.mx/nota_detalle.phpcodigo=5339162&fecha=02/04/2014.
Ng HJ, Tan WJ, Mooppil N, Newman SP, Griva K. Prevalence and patterns of anxiety in hemodialysis patients: A multi-national study. Nephrol Dial Transplant. 2020;35(9):1603-11.